boston scientific q3 news - Search News

Boston Scientific Corp Q3 Profit Decreases

YAHOO!Finance · 2h

Boston Scientific Corp (BSX) Q3 2024 Earnings Call Highlights: Robust Growth and Strategic ...

Boston Scientific Corp (BSX) reports impressive sales growth and strategic acquisitions, setting a strong foundation for future advancements.

Seeking Alpha · 1d

Boston Scientific Q3: Good Growth, But Not Good Enough To Justify Its P/E Ratio

Analysis of Boston Scientific Corporation's Q3 results, future growth projections, and potential impact of regulatory approvals on the stock. Click for more on BSX.

Insider Monkey on MSN · 17h

Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript

Q3 2024 Earnings Call Transcript October 23, 2024 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.63, expectations were $0.588. Operator: Good morning and welcome to the Boston Scientific Third Quarter 2024 Earnings Call.

11h

Boston Scientific price target raised to $98 from $95 at RBC Capital

RBC Capital raised the firm’s price target on Boston Scientific (BSX) to $98 from $95 and keeps an Outperform rating on the shares. The ...

1d

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices

On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter revenues of $4.21 billion, beating the ...

Boston Scientific boosts PFA expectations, citing rapid Farapulse adoption

Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...

15h

Boston Scientific price target raised to $98 from $87 at Wells Fargo

Wells Fargo raised the firm’s price target on Boston Scientific (BSX) to $98 from $87 and keeps an Overweight rating on the shares. The ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results